Company · CIK 1692830
Satsuma Pharmaceuticals, Inc.
| CIK | 1692830 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NC |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2019-11-12 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-249645 | 2020-10-23 | 2023-06-08 | 4 | |
| 333-255201 | 2021-04-13 | 2023-06-08 | 3 | |
| 333-268035 | 2022-10-28 | 2023-06-08 | 3 | |
| 333-233347 | 2019-08-16 | 2019-09-13 | 5 |
Filings
16| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-06-08 | EFFECTDeclared effective | 333-268035 | 9999999995-23-001678 |
| 2023-06-08 | EFFECTDeclared effective | 333-255201 | 9999999995-23-001674 |
| 2023-06-08 | EFFECTDeclared effective | 333-249645 | 9999999995-23-001673 |
| 2022-11-07 | EFFECTDeclared effective | 333-268035 | 9999999995-22-003219 |
| 2022-11-03 | 424B5Shelf takedown | 333-249645 | 0001193125-22-276956 |
| 2022-10-28 | S-3Shelf registered | 333-268035 | 0001193125-22-271265 |
| 2021-04-30 | EFFECTDeclared effective | 333-255201 | 9999999995-21-001690 |
| 2021-04-13 | S-3Shelf registered | 333-255201 | 0001193125-21-114654 |
| 2020-11-12 | EFFECTDeclared effective | 333-249645 | 9999999995-20-003155 |
| 2020-10-23 | S-3Shelf registered | 333-249645 | 0001193125-20-275551 |
| 2019-09-13 | 424B4Final prospectus | 333-233347 | 0001193125-19-244957 |
| 2019-09-12 | EFFECTDeclared effective | 333-233347 | 9999999995-19-002075 |
| 2019-09-11 | S-1/AAmendment | 333-233347 | 0001193125-19-243034 |
| 2019-09-03 | S-1/AAmendment | 333-233347 | 0001193125-19-235733 |
| 2019-08-16 | S-1Registration filed | 333-233347 | 0001193125-19-223576 |
| 2019-06-21 | DRSDraft made public | 377-02704 | 0000950123-19-006096 |